Literature DB >> 5435149

Impaired glucose tolerance: a late effect of insulin shock treatment.

R Hunter, M Jones, B A Hurn, C Duncan.   

Abstract

Glucose tolerance tests were performed in a group of patients in a mental hospital who had been treated with insulin shock and in a matched control group. Five out of 31 (16%) patients in the insulin-treated group and 1 out of 22 (5%) controls had "diabetic" blood sugar curves. Median blood sugar values were significantly higher at 60 minutes and later in the insulin-treated group, as were mean blood sugar values when the "diabetic" patients were excluded. Small amounts of plasma insulin-binding antibody were found in two insulin-treated patients. In the absence of any other clear-cut explanation, it is suggested that in some patients massive doses of insulin by injection may leave diminished tissue responsiveness to insulin as a long-term after-effect.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5435149      PMCID: PMC1699479          DOI: 10.1136/bmj.1.5694.465

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  Disturbances of carbohydrate metabolism caused by barbiturates and alcohol.

Authors:  R A HUNTER; W H MERIVALE; A J SMITH
Journal:  Lancet       Date:  1955-12-31       Impact factor: 79.321

2.  The insulin myth.

Authors:  H BOURNE
Journal:  Lancet       Date:  1953-11-07       Impact factor: 79.321

3.  The effect of insulin shock therapy on glucose metabolism in schizophrenia.

Authors:  H F BORENZ; D B SCHUSTER; G J DOWNEY
Journal:  J Nerv Ment Dis       Date:  1949-12       Impact factor: 2.254

4.  An automated micro determination of blood-glucose with the autoanalyzer.

Authors:  D E Faulkner
Journal:  Analyst       Date:  1965-12       Impact factor: 4.616

5.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.